Share on StockTwits

St. Jude Medical Inc. (NYSE:STJ) issued an update on its FY14 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $3.94-3.99 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.97, reports. The company issued revenue guidance of $5.6-5.75 billion, compared to the consensus revenue estimate of $5.64 billion.St. Jude Medical also updated its Q1 guidance to $0.94-0.96 EPS.

A number of analysts have recently weighed in on STJ shares. Analysts at Wedbush raised their price target on shares of St. Jude Medical from $62.00 to $73.00 in a research note to investors on Tuesday, January 14th. On a related note, analysts at Barclays reiterated an overweight rating on shares of St. Jude Medical in a research note to investors on Thursday, January 9th. They now have a $72.00 price target on the stock, up previously from $65.00. Finally, analysts at BTIG Research initiated coverage on shares of St. Jude Medical in a research note to investors on Tuesday, January 7th. They set a buy rating on the stock. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and eleven have assigned a buy rating to the stock. The stock currently has an average rating of Buy and a consensus price target of $56.44.

St. Jude Medical Inc. (NYSE:STJ) traded down 1.44% on Wednesday, hitting $65.01. The stock had a trading volume of 1,579,108 shares. St. Jude Medical Inc. has a 52-week low of $38.73 and a 52-week high of $68.39. The stock’s 50-day moving average is $62.10 and its 200-day moving average is $55.93. The company has a market cap of $18.971 billion and a price-to-earnings ratio of 26.93.

St. Jude Medical (NYSE:STJ) last posted its quarterly earnings results on Wednesday, January 22nd. The company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.02. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.38 billion. During the same quarter in the previous year, the company posted $0.90 earnings per share. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, analysts predict that St. Jude Medical Inc. will post $3.74 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of 0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend is Friday, December 27th.

St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.